Barclays
USNA icon

Barclays’s Usana Health Sciences USNA Stock Holding History

Barclays’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-600
Closed -$26K – 7693
2013
Q3 		$26K Sell
600
-2,800
-82% -$112K ﹤0.01% 6414
2013
Q2 		$123K Buy
+3,400
New +$103K ﹤0.01% 5615

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's USNA Position: Q2 2026 in Review

Barclays increased its Usana Health Sciences (USNA) stake by 3.3% in Q2 2026, buying an estimated $21.8K and bringing the position to 36,400 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Barclays first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.85M in Q2 2014. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Barclays held 36,400 shares of Usana Health Sciences worth $777K as of Q2 2026.
  • Barclays bought 1,159 Usana Health Sciences shares in Q2 2026, an estimated $21.8K.
  • Usana Health Sciences made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2946 holding.
  • Barclays first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Usana Health Sciences position peaked at $3.85M in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.